Article
Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre - 1 Jan 2015
Zhang Yongjun, Bao Wenlong, Li Zhijun
Abstract excerpt
OBJECTIVES: In this study, we surveyed patients with advanced non-small-cell lung cancer (NSCLC) who were undergoing tyrosine kinase inhibitor (TKI)-targeted therapy. Our aim was to determine whether epidermal growth factor receptor (EGFR) mutations in serum circulating tumor (ct)DNA are useful prognostic markers for NSCLC. Sujects and Methods: Serum samples were collected from 300 patients with NSCLC that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
